Secondary analysis of the PREVENT biopsy trial (665 men with PI-RADS 3-5 lesions): in PI-RADS 3 lesions, Black men had more clinically significant prostate cancer than White men (60% vs 27%), and Asian men had none (0% vs 27%).
Secondary analysisn = 665
Driscoll et al. Evaluating PI-RADS lesions and clinically significant prostate cancer in Black and Asian men: a PREVENT randomized clinical trial secondary analysis